MCEFX | VEUSX | MCEFX / VEUSX | |
Total Expense Ratio | 1.90 | 0.08 | 2,375% |
Annual Report Gross Expense Ratio | 2.34 | 0.08 | 2,925% |
Fund Existence | 31 years | 24 years | - |
Gain YTD | 7.306 | 27.181 | 27% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 115M | 35.1B | 0% |
Annual Yield % from dividends | 1.87 | 2.89 | 65% |
Returns for 1 year | 2.57 | 17.13 | 15% |
Returns for 3 years | 58.72 | 67.44 | 87% |
Returns for 5 years | 37.03 | 52.55 | 70% |
Returns for 10 years | 45.40 | 60.40 | 75% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IVIAX | 24.80 | N/A | N/A |
Macquarie International Core Eq A | |||
PHPIX | 27.88 | N/A | N/A |
ProFunds Pharmaceuticals UltraSector Inv | |||
IVGSX | 19.55 | N/A | N/A |
VY® Invesco Growth and Income S | |||
MDGCX | 28.80 | N/A | N/A |
BlackRock Advantage Global Investor A | |||
RTNCX | 13.92 | -0.05 | -0.36% |
Russell Inv Tax-Managed Intl Eq C |